| Category: |
Proteins And Peptides |
| Target: |
Varicella Zoster Virus ORF9 |
| Immunogen: |
See techfile |
| Reactivity: |
Mouse, Rat, Human |
| Form: |
Unconjugated |
| Purification: |
Affinity purified |
| Applications: |
WB (for other see techfile or inquire) |
| Stock availability: |
Shipped within 5-10 working days |
| Storage conditions: |
Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C |
| Warnings: |
This product is for research use only |
| Source: |
proteins, Recombinants or rec |
| Group: |
recombinants |
| Gene target: |
Varicella Zoster Virus ORF9 |
| Short name: |
Anti-Varicella Zoster Virus ORF9 (Recombinant) |
| Technique: |
E, abbex advises they will be reconstituted in a buffer soluion or culture medium for cell culture, coli recombinant proteins are , supplied as white sterile powder lyopillized, Recombinant, genetic recombinations , in Escherichia coli |
| Species: |
Viruses, Virus |
| Alternative name: |
antibody to-Varicella Zoster Virus ORF9 (recombinant) |
| Alternative technique: |
rec |
| Identity: |
3829 |
| Gene: |
FRA10A |
More about : FRA10A |
| Long gene name: |
folic acid type, fra(10)(q23, fragile site, rare, 2) , 3) or fra(10)(q24 |
| Locus: |
10q23, 2 , 3 or 10q24 |
| Discovery year: |
1986-01-01 |
| Pubmed identfication: |
15203205 |